학술논문
Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)
Document Type
Article
Author
Wei, Lai; Wang, Guiqiang; Alami, Negar N; Xie, Wen; Heo, Jeong; Xie, Qing; Zhang, Mingxiang; Kim, Yoon Jun; Lim, Seng Gee; Fredrick, Linda M; Lu, Wenjing; Liu, Wei; Kalluri, Hari V; Krishnan, Preethi; Tripathi, Rakesh; Mobashery, Niloufar; Burroughs, Margaret; Asatryan, Armen; Jia, Jidong; Hou, Jinlin
Source
In The Lancet Gastroenterology & Hepatology September 2020 5(9):839-849
Subject
Language
ISSN
2468-1253